SCHEMBL846407

SCHEMBL846407

CN1CCc2cc(OC(=O)Nc3cnc4ccccc4c3)ccc21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 7/20 0.47
RAB9A P51151 7/20 0.47
KDM4E B2RXH2 6/20 0.47
SMN1; SMN2 Q16637 5/20 0.47
HSD17B10 Q99714 4/20 0.47
TP53 P04637 2/20 0.47
HTR2C P28335 1/20 0.46
HTR2B P41595 1/20 0.46
TSHR P16473 3/20 0.44
ALDH1A1 P00352 1/20 0.44
HPGD P15428 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
POLB P06746 2/20 0.44
MAPT P10636 2/20 0.44
USP30 Q70CQ3 1/20 0.44
KDR P35968 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
PKM P14618 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL847501 0.94 KDM4E (0.48) NPC1RAB9AKDM4ESMN1; SMN2HSD17B10
SCHEMBL846869 0.88 NOTUM (0.50) NPC1RAB9AKDM4ESMN1; SMN2HSD17B10
SCHEMBL846566 0.88 HSD17B10 (0.44) NPC1RAB9AKDM4ESMN1; SMN2HSD17B10
SCHEMBL846954 0.85 TRPV1 (0.45) NPC1RAB9AKDM4ESMN1; SMN2HSD17B10
SCHEMBL846528 0.85 KDR (0.48) NPC1RAB9AKDM4ESMN1; SMN2HSD17B10
SCHEMBL846485 0.84 HSD17B10 (0.43) NPC1RAB9AKDM4ESMN1; SMN2HSD17B10
SCHEMBL846445 0.83 KDM4E (0.48) NPC1RAB9AKDM4ESMN1; SMN2HSD17B10
SCHEMBL846303 0.82 NPC1 (0.60) NPC1RAB9AKDM4ESMN1; SMN2ALDH1A1
SCHEMBL846565 0.82 SMN1; SMN2 (0.47) NPC1RAB9AKDM4ESMN1; SMN2HSD17B10
SCHEMBL846419 0.82 ACHE (0.47) NPC1RAB9AKDM4ESMN1; SMN2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1603883-B1 QUINOLINE-DERIVED AMIDE MODULATORS OF VANILLOID VR1 RECEPTOR JANSSEN PHARMACEUTICA NV (BE) 2012-03-28 EP claimed